D-0202-2025 Class II Terminated
FDA drug recall D-0202-2025 was initiated by Amerisource Health Services LLC on December 17, 2024 and is designated Class II. Reason for recall: Failed Dissolution Specifications: The recall status is terminated (terminated April 16, 2026). Affected quantity: 2,028 units (cartons of 30 individual unit doses).
Recall Details
- Product Type
- Drugs
- Report Date
- January 22, 2025
- Initiation Date
- December 17, 2024
- Termination Date
- April 16, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,028 units (cartons of 30 individual unit doses)
Product Description
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Reason for Recall
Failed Dissolution Specifications:
Distribution Pattern
Nationwide in the USA
Code Information
Lot # 1012910, Exp Date: 04/30/2025